Study of genetics in craniometaphyseal dysplasia (CMD)
Part of Bones, joints & muscles clinical trials.
This study looks at the genes and related body functions in people with craniometaphyseal dysplasia (CMD). It may help researchers understand the condition better, especially by comparing affected family members to those who are not affected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of craniometaphyseal dysplasia (CMD).
- If you do not have CMD, you can only join if you are part of a participating CMD family.
- Your family must be enrolled in the study through the study team.
- You should not be joining as someone without CMD unless you are an unaffected family member in that enrolled family.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study investigates how genetic factors affect brain development and function in families where members have brain malformations, intellectual disability, or autism. Researchers hope to identify genetic causes that could lead to better understanding and future treatments.
This trial studies people with fibromuscular dysplasia (FMD) and related conditions to learn what causes them and how they behave over time. You may also be able to join if you are a healthy person matched by age and gender to help compare results.
This study looks at cleidocranial dysplasia (CCD) using a person’s symptoms and/or genetic findings to better understand what needs care and support. It may help teams improve how CCD is recognized and managed over time.
This study looks at genetic causes of skeletal (bone growth) disorders in people who show signs based on height and bone imaging. Genetic testing may help explain what’s behind the condition, especially when it seems inherited.
This study looks at DNA changes in families with Charcot-Marie-Tooth (CMT), especially a known gene duplication called PMP22. It aims to understand what other genetic factors may change how CMT shows up, which could help future diagnosis and care.
This study is building a database of medical information and images from children with certain conditions affecting the face and skull, such as craniosynostosis, achondroplasia, and osteogenesis imperfecta. The goal is to better understand these conditions and improve future care.
Hear when a new Craniometaphyseal Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.